Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide

Circulation. 2001 Dec 18;104(25):3137-44. doi: 10.1161/hc5001.100662.

Abstract

Background: In view of growing evidence of an important endothelial paracrine regulation of cardiac function, the present study investigated the role of cardiac endothelium-derived endothelin-1 (ET-1), prostaglandins, and nitric oxide (NO) during endotoxin-induced cardiomyopathy in rabbits.

Methods and results: Immunohistochemical studies showed a marked transient coinduction of the inducible isoforms of NO synthase (NOS-2) and cyclooxygenase (COX-2) in endocardial endothelium and coronary arteriolar endothelium of hearts 12 hours after intravenous administration of lipopolysaccharide (LPS+12h); staining for both isoforms was much weaker 24 hours later (LPS+36h). Nitrotyrosine localization was similar to that of NOS-2, suggesting a NOS-2-related endothelial formation of peroxynitrite in septic hearts. Contractile performance of papillary muscles was depressed in both LPS-treated groups. In the LPS+12h group, however, isometric twitches were significantly prolonged (482+/-14 versus 420+/-14 ms in the saline-treated group, P<0.005). This twitch prolongation was completely reversed by simultaneous administration of BQ-123 and indomethacin to block endogenous ET-1 and prostaglandins, respectively. In addition, in the LPS+12h group, myocardial inotropic responsiveness to exogenous ET-1 was enhanced (P<0.01).

Conclusions: Cardiac endothelial activation and myocardial sensitization to endothelium-derived mediators may be part of an adaptive response in the early (12 hours) stages of septic cardiomyopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Binding, Competitive
  • Cardiomyopathies / etiology
  • Cardiomyopathies / metabolism*
  • Cardiomyopathies / physiopathology
  • Cyclooxygenase 2
  • Dose-Response Relationship, Drug
  • Endothelin-1 / blood
  • Endothelin-1 / pharmacology
  • Endothelins / physiology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Enzyme Inhibitors / pharmacology
  • Hemodynamics
  • Immunohistochemistry
  • Isoenzymes / drug effects
  • Isoenzymes / metabolism
  • Lipopolysaccharides / administration & dosage*
  • Male
  • Muscle Contraction / drug effects
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism*
  • Nitric Oxide / physiology
  • Nitric Oxide Synthase / drug effects
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Papillary Muscles / drug effects
  • Papillary Muscles / physiology
  • Prostaglandin-Endoperoxide Synthases / drug effects
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Prostaglandins / physiology
  • Rabbits
  • Receptor, Endothelin A
  • Receptors, Endothelin / metabolism
  • Superoxide Dismutase / pharmacology
  • Time Factors
  • omega-N-Methylarginine / pharmacology

Substances

  • Endothelin-1
  • Endothelins
  • Enzyme Inhibitors
  • Isoenzymes
  • Lipopolysaccharides
  • Prostaglandins
  • Receptor, Endothelin A
  • Receptors, Endothelin
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Superoxide Dismutase